Rosenberg, F.M.; Kamali, Z.; Voorberg, A.N.; Oude Munnink, T.H.; van der Most, P.J.; Snieder, H.; Vaez, A.; Schuttelaar, M.L.A.
Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema. Pharmaceutics 2024, 16, 476.
https://doi.org/10.3390/pharmaceutics16040476
AMA Style
Rosenberg FM, Kamali Z, Voorberg AN, Oude Munnink TH, van der Most PJ, Snieder H, Vaez A, Schuttelaar MLA.
Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema. Pharmaceutics. 2024; 16(4):476.
https://doi.org/10.3390/pharmaceutics16040476
Chicago/Turabian Style
Rosenberg, Fieke M., Zoha Kamali, Angelique N. Voorberg, Thijs H. Oude Munnink, Peter J. van der Most, Harold Snieder, Ahmad Vaez, and Marie L. A. Schuttelaar.
2024. "Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema" Pharmaceutics 16, no. 4: 476.
https://doi.org/10.3390/pharmaceutics16040476
APA Style
Rosenberg, F. M., Kamali, Z., Voorberg, A. N., Oude Munnink, T. H., van der Most, P. J., Snieder, H., Vaez, A., & Schuttelaar, M. L. A.
(2024). Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema. Pharmaceutics, 16(4), 476.
https://doi.org/10.3390/pharmaceutics16040476